CompletedNot applicableNCT05708326

A Case Crossover Study of Intermittent Fasting in CLL/SLL

Studying B-cell chronic lymphocytic leukemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
British Columbia Cancer Agency
Principal Investigator
Nicol Macpherson, MD, PhD, FRCPC
BC Cancer and University of British Columbia
Intervention
5:2 Method (intermittent fasting regimen)(behavioral)
Enrollment
6 enrolled
Eligibility
19-85 years · All sexes
Timeline
2023 – 2023

Study locations (1)

Collaborators

BC Cancer Foundation · University of Victoria

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05708326 on ClinicalTrials.gov

Other trials for B-cell chronic lymphocytic leukemia

Additional recruiting or active studies for the same condition.

See all trials for B-cell chronic lymphocytic leukemia →

← Back to all trials